Wednesday, January 11, 2012 10:40:50 PM
Zoe, I tend to agree with you. It would be foolish not to take profit (speaking of those that bought below the .0255 area). That's just good trading.
However, I bought in the same range, and have not and will not sell until my target is reached. There is WAY too much room and potential to take ATRN out of my portfolio at this time. I don't usually hold stocks....I trade them, but sometimes certain scenarios DO present themselves. That sums it up.
However, I bought in the same range, and have not and will not sell until my target is reached. There is WAY too much room and potential to take ATRN out of my portfolio at this time. I don't usually hold stocks....I trade them, but sometimes certain scenarios DO present themselves. That sums it up.
Recent PTIX News
- Protagenic Therapeutics Completes Phytanix Separation, Strengthens Balance Sheet and Repositions the Company Around PT00114 • ACCESS Newswire • 03/17/2026 12:00:00 PM
- Protagenic Therapeutics Upgrades from OTC Pink to OTCQB Venture Market • ACCESS Newswire • 03/10/2026 12:00:00 PM
- Results from Phase 1 Multiple-Dose Study of PT00114 • ACCESS Newswire • 12/09/2025 01:46:00 PM
- Protagenic Therapeutics Announces Receipt of Nasdaq Non-Compliance Notice • ACCESS Newswire • 11/27/2025 08:45:00 AM
- Protagenic Therapeutics Announces Completion of Enrollment and Dosing in Phase 1 MAD Study • ACCESS Newswire • 11/13/2025 01:22:00 PM
- Protagenic Therapeutics Announces Grant of new patent in Japan for its Modified Stilbenoid Program Drug Candidates • GlobeNewswire Inc. • 07/30/2025 12:30:00 PM
